Articles
GeoVax Labs updates investors on its COVID-19 vaccine and cancer immunotherapy clinical trials
GeoVax Labs CEO David Dodd talks to Proactive about its three separate ongoing Phase II clinical trials in developing a COVID-19 booster to mRNA vaccines, a COVID-19 vaccine to immunocompromised patients, and and a cancer immunotherapy for advanced head and neck cancer. Dodd says each are progressing well, and he says, the company is currently…
Read MoreScience Hill funding approved by Georgia General Assembly
Several UGA projects received financial support from Georgia lawmakers this session During the recent 2022 legislative session, state lawmakers voted to support the University of Georgia’s growing research enterprise by investing close to $49 million to complete the renovation of 186,000 square feet of laboratory space on a section of campus called Science Hill. The ongoing…
Read MoreCambium Co-Founders Receive “Start-Up of the Year” Award From Emory University’s Office of Tech Transfer
Approval in 2021 to begin Phase III studies on Elate Ocular® Biologic for Dry Eye Major Milestone Supporting Award Cambium Medical Technologies, a clinical stage company developing novel processed allogeneic platelets for therapeutic applications, announced today two co-founders were awarded “Start-Up of the Year” by Emory University’s Office of Technology Transfer. The award was one of…
Read MoreFour Emory professors named to American Academy of Arts and Sciences
Four Emory University faculty members have been elected to the American Academy of Arts and Sciences, one of the nation’s oldest and most prestigious honorary societies and a leading center for independent policy research. Elected this year are: Carlos del Rio, MD, executive associate dean, Emory School of Medicine & Grady Health System; Leon L.…
Read MoreGeorgia Tech’s Paul Joseph Awarded Fulbright Specialist Grant to India
Paul Joseph, a principal research scientist in the Institute for Electronics and Nanotechnology (IEN) at Georgia Tech, has received a Fulbright Specialist Award to India from the Fulbright Foreign Scholarship Board. Joseph will spend two weeks at the Indian Institute of Information technology (IIIT) this summer helping to expand the nanotechnology curriculum and assisting with…
Read MoreSaol Therapeutics Announces First Patient Dosed in Phase 2 RAISE Spasticity Trial Evaluating the Safety Profile of SL-1002 for Limb Spasticity
Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, announced today that the first patient has been enrolled in the company’s Phase 2 RAISE Spasticity Trial. SL-1002 is a novel, proprietary, nerve-blocking agent currently under development at Saol Therapeutics and is being evaluated in the RAISE Spasticity Trial. The trial is a double-blind, placebo-controlled, single ascending-dose…
Read MoreMissing our great physicist Sérgio Mascarenhas, defender of science
The passing of the scientist, physicist and chemist was mourned by all those who believe in scientific development, democratization of education and science as a way to build a fairer society in Brazil, with more health and access to all. Professor at the Institute of Physics of São Carlos, University of São Paulo, and honorary…
Read MoreBioMarin Pharmaceutical commemorates 5 years of helping children with fatal rare disease
CLN2 Batten disease is a rare, inherited, fatal disorder that primarily affects the nervous system as a result of a failure to produce enough of the enzyme TPP1. The signs and symptoms of this condition typically start between the ages of 2 and 4, featuring recurrent seizures and coordination difficulty. BioMarin Pharmaceutical in San Rafael…
Read MoreSaol Therapeutics and InformedDNA Partner to Offer Genetic Counseling to Patients with Rare Mitochondrial Disease
Program Discusses Access to a Pivotal Phase 3 Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency (DCA/PDCD trial; NCT02616484) Saol Therapeutics, a company researching new treatments for rare diseases, is pleased to announce a partnership with InformedDNA®, the nation’s leading applied genomics solutions company, to offer genetic counseling for the families of individuals with a…
Read MoreGeorgia Bio Names South Forsyth High School Junior as 2022 Georgia BioGENEius Winner
Mokshith Mannuru Advances to International Competition Against Top Students Georgia Bio and the BioEd Institute named Mokshith Mannuru, a junior at South Forsyth High School in Cumming, GA, as the winner of the 2022 Georgia BioGENEius Challenge. The BioGENEius Challenge is the premier competition for high school students that recognizes outstanding research and innovation in the…
Read More